World-class Cancer Care Tailored to You
The Cancer Center at Beth Israel Deaconess Medical Center is renowned for exceptional cancer care and for pioneering discoveries that have led to powerful cancer treatment strategies. We offer the most up-to-date treatments, but we are not satisfied with the standard of care. Our physician-scientists aspire to the Standard of Cure.
We also believe that success is measured one patient at a time. We respect the dignity, values, needs and opinions of each person we are privileged to treat. We help our patients and their families understand and weigh treatment options, and help sort through the medical and very personal decision-making process they face.
Ours is a team effort. We assemble leading experts to identify and deliver the best possible treatment plan for you. In our multidisciplinary clinics, our patients see all key specialists in one visit for easy access and coordinated planning. We offer a wide range of support services to help sustain you and your family during and after treatment.
We provide our patients with the most advanced, personalized cancer therapies. We deliver cutting edge treatment and healing focused on the patient and family experience. This care is informed by our breakthrough research platforms incorporating RNA medicine, immunotherapies, organoids and co-clinical trials at the Mouse Hospital. Our cancer clinicians, researchers, educators and staff strive to deliver ultraprecision medicine that exceeds the standard of care while striving for the Standard of Cure.
BIDMC's Leon V. and Marilyn L. Rosenberg Clinical Cancer Center is the only cancer center in Massachusetts, and one of
only 34 in the country, to receive the Outstanding Achievement Award from
the Commission on Cancer of the American College of Surgeons. The
commission is a consortium of professional organizations that includes the
American Cancer Society, the Society of Surgical Oncology, the American
Society of Clinical Oncology, the American College of Radiology, the
Oncology Nursing Society the American College of Surgeons. The commission's
goal is to reduce cancer death and disease by promoting education, setting
standards and monitoring the quality of care that is delivered.
BIDMC is a member of the Harvard Cancer Collaborative. It continues to earn high marks in patient satisfaction surveys for our
clinical excellence in cancer care and related services.
The Cancer Center is a major center of cancer research, encompassing basic research, translational research and clinical trials. Our Cancer Clinical Trials Office provides patients with experimental treatment options that go beyond the standard of care. The Cancer Research Institute's researchers are responsible for breakthroughs across the spectrum of cancer science, from genetics to signal transduction to RNA medicine and beyond. BIDMC, a founding member of the Dana-Farber/Harvard Cancer Center, is a major recipient of funding from the National Institutes of Health.
The Cancer Center at Beth Israel Deaconess Medical Center delivers advanced cancer care in collaboration with affiliates throughout Eastern Massachusetts. The Cancer Center has formed these affiliations with community-based colleagues who share our commitment to providing patients with personalized treatment, clinical excellence and compassionate care.
Typically patients receive most of their care in the community setting. When diagnostic tools or specialized procedures that are not available in the community are needed, the community-based oncologist makes a seamless referral to the BIDMC Cancer Center in Boston.
Learn More about the Cancer Center at BIDMC
Our annual reports provide a summary of our activities and outcomes. Click below to learn more about each year in numbers, the year in review, supportive services, community outreach, program outcomes, quality and process improvements and a host of other information.
2016 Annual Report
2015 Annual Report